跳至主要内容
临床试验/IRCT20180412039284N2
IRCT20180412039284N2尚未招募未知

The effect of chitosan supplementation on changes of weight, glycemic risk factors, lipid profile, serum inflammatory factors, adipokines and total antioxidant capacity in patients with nonalcoholic fatty liver disease (NAFLD)

Ahvaz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Aged between 18-65 years (both genders)
  • Diagnosis of nonalcoholic fatty liver disease by ultrasound
  • Willingness to participate
  • No allergies to seafood

排除标准

  • Suffering from viral hepatitis, liver cirrhosis, Wilson's disease, acute fatty liver, hepatocellular carcinoma, hypothyroidism, lipodystrophy, diseases that involves bile ducts
  • History of chronic liver disease
  • History of significant weight loss (more than 10% of body weight during 6 months ago) or weight loss surgery
  • History of antioxidant supplementation, omega 3 and milk thistle during 6 months ago
  • History of liver damaging drugs
  • History of cardiovascular
  • History of renal disease
  • Alcohol consumption more than 20 gram per day
  • Energy consumption less than 800 or more than 4200 kilocalorie per day

研究者

相似试验